$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000143774919009839 Filed on May 14, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018 Q1
Revenue	$1.916M	$3.766M	$1.806M
YoY Change	6.11%	69.63%	-51.05%
Cost Of Revenue	$618.7K	$1.864M	$562.7K
YoY Change	9.96%	88.33%	-59.87%
Gross Profit	$1.297M	$1.901M	$1.243M
YoY Change	4.37%	55.84%	-45.65%
Gross Profit Margin	67.71%	50.49%	68.84%
Selling, General & Admin	$2.109M	$1.897M	$3.019M
YoY Change	-30.14%	-35.27%	11.49%
% of Gross Profit	162.58%	99.76%	242.88%
Research & Development	$6.346K	$29.98K	$225.8K
YoY Change	-97.19%	-0.07%	115.03%
% of Gross Profit	0.49%	1.58%	18.17%
Depreciation & Amortization	$26.05K	$26.17K	$265.0K
YoY Change	-90.17%	-92.3%	667.16%
% of Gross Profit	2.01%	1.38%	21.32%
Operating Expenses	$2.115M	$1.927M	$3.245M
YoY Change	-34.8%	-35.13%	15.36%
Operating Profit	-$818.2K	-$25.41K	-$2.002M
YoY Change	-59.13%	-98.55%	280.59%
Interest Expense	$41.28K	$1.310K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$2.264K	-$1.990K	-$1.700K
YoY Change	33.18%		40.61%
Pretax Income	-$779.2K	-$26.09K	-$2.001M
YoY Change	-61.06%	-98.5%	280.09%
Income Tax	$4.465K	$6.830K	$11.46K
% Of Pretax Income
Net Earnings	-$782.8K	$179.9K	-$1.874M
YoY Change	-58.23%	-110.05%	271.18%
Net Earnings / Revenue	-40.86%	4.78%	-103.79%
Basic Earnings Per Share	-$0.02		-$0.06
Diluted Earnings Per Share	-$0.02	$5.005K	-$0.06
COMMON SHARES
Basic Shares Outstanding	40.53M		34.77M
Diluted Shares Outstanding	40.53M		34.77M

Balance Sheet

Concept	2019 Q1	2018 Q4	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.740M	$743.4K	$2.090M
YoY Change	31.09%	-71.84%	-28.91%
Cash & Equivalents	$2.740M	$1.996M	$2.094M
Short-Term Investments
Other Short-Term Assets	$620.5K	$464.5K	$1.600M
YoY Change	-61.22%	-70.03%	131.88%
Inventory	$1.861M	$1.921M	$3.265M
Prepaid Expenses
Receivables	$1.513M	$1.978M	$833.8K
Other Receivables	$0.00	$0.00	$500.0K
Total Short-Term Assets	$7.314M	$5.856M	$11.01M
YoY Change	-33.55%	-51.28%	-2.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$77.87K	$82.56K	$115.5K
YoY Change	-32.58%	-41.76%	-18.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.36K	$26.88K	$26.88K
YoY Change	-35.43%	0.0%	0.0%
Total Long-Term Assets	$647.2K	$544.7K	-$4.606M
YoY Change	-114.05%	-84.9%	-207.34%
TOTAL ASSETS
Total Short-Term Assets	$7.314M	$5.856M	$11.01M
Total Long-Term Assets	$647.2K	$544.7K	-$4.606M
Total Assets	$7.962M	$6.401M	$6.401M
YoY Change	24.38%	-59.04%	-59.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.199M	$1.059M	$1.557M
YoY Change	-23.0%	8.34%	75.1%
Accrued Expenses	$1.548M	$794.9K	$1.929M
YoY Change	-19.72%	-63.52%	49.01%
Deferred Revenue	$50.00K	$100.0K
YoY Change		-94.2%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.219M	$4.873M	$7.001M
YoY Change	-25.45%	-27.58%	93.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$15.92K	$0.00	$1.400M
YoY Change	-98.86%	-100.0%
Total Long-Term Liabilities	$15.92K	$0.00	$1.400M
YoY Change	-98.86%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.219M	$4.873M	$7.001M
Total Long-Term Liabilities	$15.92K	$0.00	$1.400M
Total Liabilities	$5.235M	$4.873M	$8.401M
YoY Change	-37.68%	-40.05%	134.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.78M	-$86.00M	-$80.44M
YoY Change	7.88%	9.46%	8.87%
Common Stock	$90.44M	$88.45M	$87.15M
YoY Change	3.78%	1.99%	4.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K	$911.5K
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K	$33.33K
Shareholders Equity	$2.748M	$1.540M	$5.796M
YoY Change
Total Liabilities & Shareholders Equity	$7.962M	$6.401M	$14.35M
YoY Change	-44.53%	-59.04%	18.13%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018 Q1
OPERATING ACTIVITIES
Net Income	-$782.8K	$179.9K	-$1.874M
YoY Change	-58.23%	-110.05%	271.18%
Depreciation, Depletion And Amortization	$26.05K	$26.17K	$265.0K
YoY Change	-90.17%	-92.3%	667.16%
Cash From Operating Activities	-$220.2K	$329.5K	-$541.4K
YoY Change	-59.33%	-0.15%	-38.06%
INVESTING ACTIVITIES
Capital Expenditures	$8.104K	-$890.00	$1.368K
YoY Change	492.4%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$8.104K	-$890.00	-$1.368K
YoY Change	492.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.975M		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.225M	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-220.2K	329.5K	-541.4K
Cash From Investing Activities	-8.104K	-890.0	-1.368K
Cash From Financing Activities	2.225M	0.000
Net Change In Cash	1.996M	328.6K	-542.7K
YoY Change	-467.83%	-0.42%	-17.85%
FREE CASH FLOW
Cash From Operating Activities	-$220.2K	$329.5K	-$541.4K
Capital Expenditures	$8.104K	-$890.00	$1.368K
Free Cash Flow	-$228.3K	$330.4K	-$542.7K
YoY Change	-57.94%	0.12%	-37.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q1	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	110215
CY2018Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
CY2019Q1	mlss	Class Of Warrant Or Right Exerciable During Period ClassOfWarrantOrRightExerciableDuringPeriod	3249171
CY2018Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2012168
CY2019Q1	mlss	Class Of Warrant Or Right Exercisable Exercise Price ClassOfWarrantOrRightExercisableExercisePrice	1.45
CY2019Q1	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod
CY2019Q1	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice
CY2019Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2019Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
CY2019Q1	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
CY2019Q1	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
CY2019Q1	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	90000
CY2019Q1	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	431364
CY2018Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	421800
CY2019Q1	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed	406045
CY2018Q1	mlss	Derivative Liability Assumed DerivativeLiabilityAssumed
CY2019Q1	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	1878704
CY2018	mlss	Equity Method Investment Summarized Financial Information Other Expenses EquityMethodInvestmentSummarizedFinancialInformationOtherExpenses	1252213
CY2019Q1	mlss	Equity Securities Issued EquitySecuritiesIssued	1840000
CY2018Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1539794
CY2019Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-783631
CY2019Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	110215
CY2018Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties
CY2019Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-118669
CY2018Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	287216
CY2019Q1	mlss	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability	-39555
CY2018Q1	mlss	Increase Decreasein Operating Lease Liability IncreaseDecreaseinOperatingLeaseLiability
CY2019Q1	mlss	Increase In Operating Lease Right Of Use Asset IncreaseInOperatingLeaseRightOfUseAsset	-39555
CY2018Q1	mlss	Increase In Operating Lease Right Of Use Asset IncreaseInOperatingLeaseRightOfUseAsset
CY2019Q1	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	166292
CY2018Q1	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred
CY2019Q1	mlss	Operating Lease Rightofuse Liability OperatingLeaseRightofuseLiability	166292
CY2018Q1	mlss	Operating Lease Rightofuse Liability OperatingLeaseRightofuseLiability
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
CY2019Q1	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
CY2019Q1	mlss	Reclassification Of Warrants And Shares To Be Issued ReclassificationOfWarrantsAndSharesToBeIssued	-406045
CY2019Q1	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered	7500
CY2018Q1	mlss	Shares Issue To Board Of Directors For Services Rendered SharesIssueToBoardOfDirectorsForServicesRendered
CY2019Q1	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	40000
CY2018Q1	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments
CY2019Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	61500
CY2018Q1	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses	339500
CY2019Q1	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	7000
CY2018Q1	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation
CY2019Q1	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors	61500
CY2018Q1	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors	339500
CY2019Q1	mlss	Warrants And Rights Exercisable Weighted Average Remaining Term WarrantsAndRightsExercisableWeightedAverageRemainingTerm	P2Y343D
CY2019Q1	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y310D
CY2018	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P266D
CY2019Q1	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y343D
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1198624
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1205396
CY2019Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1400806
CY2018Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1663849
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1512746
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1978456
CY2019Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	50000
CY2018Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	100000
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1548353
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1481715
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	90398875
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	88414718
CY2019Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	530114
CY2018Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	648783
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56988
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	86809
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13252
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	237366
CY2019Q1	us-gaap	Assets Assets	7961631
CY2018Q4	us-gaap	Assets Assets	6400968
CY2018Q1	us-gaap	Assets Assets	6400968
CY2019Q1	us-gaap	Assets Current AssetsCurrent	7314404
CY2018Q4	us-gaap	Assets Current AssetsCurrent	5856260
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2739700
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	743429
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2636956
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2094238
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1996271
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-542718
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.45
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1500000
CY2019Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3249171
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40855721
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33859034
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40822388
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33825701
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	43662
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	36330
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	50000
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	618694
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	562676
CY2019Q1	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2807710
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2470565
CY2019Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	24602
CY2018Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	50000
CY2019Q1	us-gaap	Depreciation Depreciation	12792
CY2018Q1	us-gaap	Depreciation Depreciation	27625
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26045
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264991
CY2019Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	365785
CY2018Q4	us-gaap	Derivative Liabilities DerivativeLiabilities
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	17593789
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	15191133
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	235100
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Cost Of Sales EquityMethodInvestmentSummarizedFinancialInformationCostOfSales	447611
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	21914957
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Current Liabilities EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities	17696033
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-4321168
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Equity EquityMethodInvestmentSummarizedFinancialInformationEquity	-2504900
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	369228
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Gross Profit Loss EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss	309345
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	17593789
CY2018Q4	us-gaap	Equity Method Investment Summarized Financial Information Liabilities And Equity EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity	15191133
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-1509476
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Net Income Loss EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss	-942868
CY2019Q1	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	604328
CY2018	us-gaap	Equity Method Investment Summarized Financial Information Revenue EquityMethodInvestmentSummarizedFinancialInformationRevenue	756956
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1500000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2042443
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4017510
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	422021
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	435273
CY2019Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	40260
CY2018Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q1	us-gaap	Gross Profit GrossProfit	1297215
CY2018Q1	us-gaap	Gross Profit GrossProfit	1242929
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-779166
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2000704
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-9564
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	36783
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4465
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11464
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6772
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	579070
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-263043
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	89400
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-465710
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-701677
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-50000
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	182638
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-19757
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-50000
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability
CY2019Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-25398
CY2018Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-59760
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-114151
CY2019Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-9523
CY2018Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	181410
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	58307
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1019
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2664
CY2019Q1	us-gaap	Inventory Net InventoryNet	1861291
CY2018Q4	us-gaap	Inventory Net InventoryNet	1921051
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	756000
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	763000
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	108952
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	123918
CY2019Q1	us-gaap	Lease Cost LeaseCost	39555
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	134640
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15976
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	118664
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4658
CY2019Q1	us-gaap	Liabilities Liabilities	5235129
CY2018Q4	us-gaap	Liabilities Liabilities	4872760
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7961631
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6400968
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5219205
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4872760
CY2019Q1	us-gaap	Minority Interest MinorityInterest	-21845
CY2018Q4	us-gaap	Minority Interest MinorityInterest	-11402
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2224546
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8104
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1368
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-220171
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-541350
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-782752
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-1873978
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10443
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-101407
CY2019Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2019Q1	us-gaap	Open Tax Year OpenTaxYear	2015 2016 2017
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	2115396
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	3244597
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-818181
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2001668
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	39555
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	129000
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	129982
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114058
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-793195
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15924
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	39555
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129000
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129982
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P328D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	238939
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four And Five Years OperatingLeasesFutureMinimumPaymentsDueInFourAndFiveYears
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two And Three Years OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	16419
CY2019Q1	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	0
CY2018Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	0
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17355
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26878
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2264
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1700
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8104
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1368
CY2019Q1	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	7000000
CY2018Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	7000000
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7000
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	7000
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7000
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	7000
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	7
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	7
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	595951
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	414541
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div>  Reclassifications</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">Certain reclassifications have been made to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> financial statements to conform to the condensed  consolidated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on net loss or cash flows as previously reported.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1974546
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2018Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-1975385
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	77869
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82557
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6346
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	225817
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-86782681
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85999929
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1915909
CY2018Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1805605
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2109050
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3018780
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	56988
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	86809
CY2019Q1	us-gaap	Share Price SharePrice	0.33
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7500
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	2748347
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1539610
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2726502
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7500628
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5951552
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40531762
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.</div>  Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 7.2pt;text-align:left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates<div style="display: inline; font-weight: bold;">.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40531762
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34766014
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34766014

Files In Submission

Name	View Source	Status
0001437749-19-009839-index-headers.html	Edgar Link	pending
0001437749-19-009839-index.html	Edgar Link	pending
0001437749-19-009839.txt	Edgar Link	pending
0001437749-19-009839-xbrl.zip	Edgar Link	pending
ex_141621.htm	Edgar Link	pending
ex_141622.htm	Edgar Link	pending
ex_141623.htm	Edgar Link	pending
ex_141624.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20190331.xml	Edgar Link	completed
mlss-20190331.xsd	Edgar Link	pending
mlss-20190331_cal.xml	Edgar Link	unprocessable
mlss-20190331_def.xml	Edgar Link	unprocessable
mlss-20190331_lab.xml	Edgar Link	unprocessable
mlss-20190331_pre.xml	Edgar Link	unprocessable
mlss20190331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q1 Form 10-Q Financial Statement

#000143774919009839 Filed on May 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2019 Q1 Form 10-Q Financial Statement

#000143774919009839 Filed on May 14, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss